Blogopmaak
Developing genetic treatments for patients with very rare mutations
Annemieke Aartsma-Rus published an article about DCRT in Nature Medicine! In this article Annemieke tells about "N of 1" therapies, RNA therapies that are only suitable for one patient. DCRT is developing individualized ASOs for
patients with genetic brain or eye disorders and Annemieke summarizes the challenges that we face in these studies.
To read the whole article, go to Nature Medicine Worldview of 24th of May 2021.
published on May 25, 2021
Annemieke Aartsma-Rus presented at the Swiss RNA Therapeutics Summit at the University of Bern
DCRT's Ype Elgersma will talk on television about his work on epilepsy
Happy Christmas holidays from all of us at DCRT!
Guest researchers at the DCRT
Join us on 12 and 13 June 2025 in Groningen, The Netherlands, for the 4th Dutch Antisense Therapeutics Symposium
DCRT interview in the newsletter of Centre for Future Affordable Sustainable Therapy Development (FAST)
DCRT travel grant recipients, Edwin van Oosten and Raúl Andrés about the OTS meeting
First DCRT newsletter
Marlen Lauffer, Emilio Harris-Mostert and Edwin van Oosten received an OTS poster award
Cake and candles for 12.5 years at LUMC